International Expert Consensus on Switching Platelet P2Y 12 Receptor–Inhibiting Therapies

J. Angiolillo, Dominick; Rollini, Fabiana; F. Storey, Robert; L. Bhatt, Deepak; James, Stefan; J. Schneider, David; Sibbing, Dirk; So, Derek; Trenk, Dietmar; Alexopoulos, Dimitrios; A. Gurbel, Paul; Hochholzer, Willibald; De Luca, Leonardo; Bonello, Laurent; Aradi, Dániel; Cuisset, Thomas; S. Tantry, Udaya; Y. Wang, Tracy; Valgimigli, Marco; Waksman, Ron; Mehran, Roxana; Montalescot, Gilles; Franchi, Francesco; J. Price, Matthew

doi:10.1161/circulationaha.117.031164

Public

International Expert Consensus on Switching Platelet P2Y 12 Receptor–Inhibiting Therapies

Published in Circulation • Oct 30, 2017

Authors:

Dominick J. Angiolillo

Fabiana Rollini

Robert F. Storey

Abstract

Dual antiplatelet therapy with aspirin and a P2Y 12 inhibitor is the treatment of choice for the prevention of atherothrombotic events in patients with acute coronary syndromes and for those undergoing percutaneous coronary interventions. The availability of different oral P2Y 12 inhibitors (clopido...

Subject

Prasugrel

Medicine

Ticagrelor

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!